Pacer Advisors Inc. Has $2.83 Million Stock Holdings in Ventas, Inc. $VTR

Pacer Advisors Inc. lessened its stake in shares of Ventas, Inc. (NYSE:VTR) by 27.6% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 34,580 shares of the real estate investment trust’s stock after selling 13,192 shares during the quarter. Pacer Advisors Inc.’s holdings in Ventas were worth $2,828,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the company. Vanguard Group Inc. raised its stake in Ventas by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 75,948,003 shares of the real estate investment trust’s stock worth $5,876,856,000 after buying an additional 2,349,176 shares during the period. State Street Corp raised its position in shares of Ventas by 2.5% during the fourth quarter. State Street Corp now owns 29,662,635 shares of the real estate investment trust’s stock worth $2,309,234,000 after purchasing an additional 735,620 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Ventas by 3.8% in the 4th quarter. Geode Capital Management LLC now owns 12,988,943 shares of the real estate investment trust’s stock worth $1,001,447,000 after purchasing an additional 475,633 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in Ventas by 27.9% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 9,176,254 shares of the real estate investment trust’s stock valued at $710,060,000 after purchasing an additional 2,000,341 shares during the period. Finally, Capital World Investors bought a new stake in Ventas during the 4th quarter valued at $594,116,000. 94.18% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on VTR shares. Cantor Fitzgerald raised their price objective on shares of Ventas from $97.00 to $102.00 and gave the company an “overweight” rating in a research note on Friday, July 31st. Scotiabank dropped their price target on shares of Ventas from $95.00 to $88.00 and set a “sector perform” rating on the stock in a research report on Thursday, June 18th. KeyCorp boosted their price objective on Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a report on Thursday, May 7th. Barclays initiated coverage on Ventas in a research note on Tuesday, July 7th. They issued an “equal weight” rating and a $99.00 price objective for the company. Finally, Wells Fargo & Company raised their target price on Ventas from $93.00 to $96.00 and gave the company an “overweight” rating in a report on Monday, June 1st. Fifteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $97.56.

Ventas Trading Down 0.3%

Shares of Ventas stock opened at $92.22 on Friday. The firm has a market cap of $47.30 billion, a PE ratio of 170.78, a P/E/G ratio of 2.14 and a beta of 0.69. Ventas, Inc. has a 1 year low of $66.38 and a 1 year high of $101.60. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.44 and a quick ratio of 0.44. The stock has a fifty day moving average price of $89.32 and a 200-day moving average price of $86.05.

Ventas Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, July 16th. Investors of record on Tuesday, June 30th were issued a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date was Tuesday, June 30th. Ventas’s dividend payout ratio (DPR) is 385.19%.

Insider Activity

In related news, Director Michael J. Embler purchased 2,500 shares of the firm’s stock in a transaction dated Wednesday, June 3rd. The stock was bought at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the purchase, the director directly owned 19,202 shares in the company, valued at approximately $1,513,309.62. This trade represents a 14.97% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Walter C. Rakowich sold 1,152 shares of Ventas stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $90.20, for a total transaction of $103,910.40. Following the completion of the sale, the director directly owned 28,349 shares in the company, valued at $2,557,079.80. This trade represents a 3.90% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.53% of the company’s stock.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.